Economic evaluation of caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia in Sweden

By Naik Shalini   Lundberg Johan   Kumar Ritesh   Sjolin Jan   Jansen Jeroen P.  

Scandinavian Journal of Infectious Diseases, Vol. 43, Iss. 6-7, 2011-07 ,pp. : 504-514

Informa Healthcare

Access to resources Recommend Favorite

Post‐antifungal effect and adhesion to buccal epithelial cells of oral Candida dubliniensis isolates subsequent to limited exposure to amphotericin B, ketoconazole and fluconazole

By  

JOURNAL OF INVESTIGATIVE AND CLINICAL DENTISTRY (ELECTRONIC), Vol. 6, Iss. 3, 2015-08 ,pp. : 186-192

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost-Benefit Assessment of Antifungal Prophylaxis with Liposomal Amphotericin B in Neutropenic Patients

By  

Oncology Research and Treatment, Vol. 30, Iss. 12, 2007-11 ,pp. : 621-626

Karger

Access to resources Recommend Favorite

Fluconazole Therapy in Candida albicans Spondylodiscitis

By Rössel Petra   Schønheyder Henrik C.   Nielsen Henrik  

Scandinavian Journal of Infectious Diseases, Vol. 30, Iss. 5, 1998-12 ,pp. : 527-530

Informa Healthcare

Access to resources Recommend Favorite

Activity of Voriconazole: Post-antifungal Effect, Effects of Low Concentrations and of Pretreatment on the Susceptibility of Candida albicans to Leucocytes

By García M. T.   Llorente M. T.   Lima J. E.   Mínguez F.   Del Moral F.   Prieto J.  

Scandinavian Journal of Infectious Diseases, Vol. 31, Iss. 5, 1999-10 ,pp. : 501-504

Informa Healthcare

Access to resources Recommend Favorite